Better Therapeutics stock surges after FDA approves smartphone-based diabetes treatment
Better Therapeutics Inc. shares surged in the extended session Monday after the digital therapeutics company got Food and Drug Administration ...
Read moreTag: Product/Service Approvals
Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
Eisai shares 4523, +7.37% rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on Leqembi raised ...
Read more
